ClinVar Miner

Submissions for variant NM_024301.5(FKRP):c.731G>A (p.Arg244His) (rs764641619)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000725201 SCV000334847 uncertain significance not provided 2017-07-10 criteria provided, single submitter clinical testing
Invitae RCV000457561 SCV000548508 uncertain significance Walker-Warburg congenital muscular dystrophy 2019-12-13 criteria provided, single submitter clinical testing This sequence change replaces arginine with histidine at codon 244 of the FKRP protein (p.Arg244His). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and histidine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has been reported in homozygous state in an individual affected with Limb-Girdle Muscular Dystrophy Type 2I and the muscle biopsy of the patient showed that the functional glycosylation of -dystroglycan was approximately 20% of control levels (PMID: 16344347, 17952692). ClinVar contains an entry for this variant (Variation ID: 283038). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The histidine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Genetic Services Laboratory, University of Chicago RCV000331999 SCV000594784 uncertain significance not specified 2016-06-30 criteria provided, single submitter clinical testing
GeneDx RCV000725201 SCV000617404 uncertain significance not provided 2021-02-13 criteria provided, single submitter clinical testing Immunohistochemical analysis noted a depletion of alpha-dystroglycan glycosylation and mildly reduced alpha-dystroglycan on muscle biopsy from the patient (Boito et al., 2007); In silico analysis supports that this missense variant does not alter protein structure/function; Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 16344347, 26990548, 17952692, 30564623)
Counsyl RCV000664793 SCV000788808 uncertain significance Limb-girdle muscular dystrophy-dystroglycanopathy, type C5 2016-12-16 criteria provided, single submitter clinical testing
CeGaT Praxis fuer Humangenetik Tuebingen RCV000725201 SCV001250132 pathogenic not provided 2017-09-01 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000725201 SCV001475118 uncertain significance not provided 2019-11-12 criteria provided, single submitter clinical testing
Natera, Inc. RCV000664793 SCV001460339 uncertain significance Limb-girdle muscular dystrophy-dystroglycanopathy, type C5 2020-01-12 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.